There were 1,994 press releases posted in the last 24 hours and 263,317 in the last 365 days.
Insulin Syringes Market Share
Increase in prevalence of diabetes, surge in the geriatric population, and rise in healthcare expenditure have boosted the growth of insulin syringes market.
PORTLAND, OREGON, UNITED STATES, October 12, 2022 /EINPresswire.com/ —
Allied Market Research recently published a report, titled, "๐๐ง๐ฌ๐ฎ๐ฅ๐ข๐ง ๐๐ฒ๐ซ๐ข๐ง๐ ๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐ฒ๐ซ๐ข๐ง๐ ๐ ๐๐ข๐ณ๐ (3/10 ๐๐ ๐๐ฒ๐ซ๐ข๐ง๐ ๐ (0.3๐ฆ๐ฅ), 1/ 2 ๐๐ ๐๐ฒ๐ซ๐ข๐ง๐ ๐ (0.5๐ฆ๐ฅ), 1๐๐ ๐ฌ๐ฒ๐ซ๐ข๐ง๐ ๐ (1๐ฆ๐ฅ), ๐๐ง๐ ๐๐ญ๐ก๐๐ซ๐ฌ), ๐๐ข๐ฌ๐๐๐ฌ๐ (๐๐ฒ๐ฉ๐-1 ๐๐ข๐๐๐๐ญ๐๐ฌ ๐๐ง๐ ๐๐ฒ๐ฉ๐-2 ๐๐ข๐๐๐๐ญ๐๐ฌ), ๐๐ง๐ ๐๐ฌ๐๐ซ (๐๐จ๐ฌ๐ฉ๐ข๐ญ๐๐ฅ & ๐๐ฅ๐ข๐ง๐ข๐๐ฌ, ๐๐จ๐ฆ๐๐๐๐ซ๐ ๐๐๐ญ๐ญ๐ข๐ง๐ ๐ฌ, ๐๐ง๐ ๐๐ญ๐ก๐๐ซ๐ฌ): ๐๐ฅ๐จ๐๐๐ฅ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐ง๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐
๐จ๐ซ๐๐๐๐ฌ๐ญ, 2021โ2030". As per the report, the global insulin syringes industry was pegged at $1.56 billion in 2020, and is expected to reach $2.40 billion by 2030, growing at a CAGR of 4.4% from 2021 to 2030.
๐
๐จ๐ซ ๐๐ข๐ ๐ก๐ญ ๐๐๐ซ๐ฌ๐ฉ๐๐๐ญ๐ข๐ฏ๐ ๐๐ง๐ ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ: https://www.alliedmarketresearch.com/request-sample/3740
An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needles, a barrel, and a plunger, and is available in various sizes. The needle is usually thin and short and covered with a special material such as silicone in order to allow it to slide through the skin causing minimal pain. Barrel is the chamber that holds the insulin. It is marked with calibrations designed to show the units of insulin being injected. The plunger is the narrow rod that slides up and down the length of the barrel. it serves to either draw the insulin into the barrel or release the insulin from the barrel through the needle. Further, the size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.
๐๐๐ฃ๐จ๐ซ ๐๐๐ญ๐๐ซ๐ฆ๐ข๐ง๐๐ง๐ญ๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก
Insulin syringes market are increase in the incidence of obesity and adoption of unhealthy lifestyle across the world supplement the market growth. In addition, rise in healthcare spending for diabetes across the world also fuel the growth of insulin syringes market. Furthermore, surge in the prevalence of various chronic diseases such as type1 and type2 diabetes, is another major factor that boosts the market growth. However, increase use of insulin pens and high costs of advanced insulin syringes are the factors that could hinder the growth of market. Conversely, growing in awareness of insulin syringes among population in developing economies is expected to offer lucrative opportunities during the forecast period.
๐๐จ๐ฏ๐ข๐-19 ๐ฌ๐๐๐ง๐๐ซ๐ข๐จ:
โค The Covid-19 pandemic led to a lockdown and imposed social distancing measures across several countries. The lockdown disrupted the supply chain, production, and distribution.
โค Patients with high blood pressure and diabetes are at higher risk of getting affected by the virus. Thus, the demand for insulin administration surged during the pandemic.
๐๐จ ๐๐จ๐ฎ ๐๐๐ฏ๐ ๐๐ง๐ฒ ๐๐ฎ๐๐ซ๐ฒ ๐๐ซ ๐๐ฉ๐๐๐ข๐๐ข๐ ๐๐๐ช๐ฎ๐ข๐ซ๐๐ฆ๐๐ง๐ญ? ๐๐ฌ๐ค ๐ญ๐จ ๐๐ฎ๐ซ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ฑ๐ฉ๐๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/3740
๐๐ก๐ ๐๐ฅ๐ข๐ง๐ข๐๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐๐จ๐ฆ๐ข๐ง๐๐ญ๐๐ ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ
By end user, the hospital & clinics segment held the largest share in 2020, contributing to nearly half of the market. In addition, the segment is projected to manifest the highest CAGR of 5.3% during the forecast period, owing to rise in prevalence of chronic diseases such as diabetes and increase in elderly population. The report also analyzes the segments including homecare and others.
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐ก๐๐ฅ๐ ๐ญ๐ก๐ ๐ฅ๐ข๐จ๐ง'๐ฌ ๐ฌ๐ก๐๐ซ๐
By region, the market across North America held the largest share in 2020, accounting for nearly two-fifths of the market. This is due to high expenditure on R&D, well-established healthcare infrastructure, and presence of major players & their product availability. However, the market across Asia-Pacific is expected to register the highest CAGR of 6.5% during the forecast period, owing to improvement in R&D facilities, rapidly developing economic conditions, and disposable income.
๐๐๐ฃ๐จ๐ซ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ
โคNovo Nordisk A/S
โคAbbott Laboratories
โคBiocon Ltd.
โคCardinal Health Inc.
โคTerumo Corporation
โคEli Lilly and Company
โคBeckton and Dickinson Company
โคNipro Medical Corporation
โคMedline Industries
โคHindustan syringe and medical device Ltd.
๐๐ฒ ๐๐ฒ๐ซ๐ข๐ง๐ ๐ ๐๐ข๐ณ๐
3/10 CC Syringe (0.3ml)
1/2 CC Syringe (0.5ml)
1CC Syringe (1ml)
Others
๐๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐
Type 1 Diabetes
Type 2 Diabetes)
๐๐ฒ ๐๐ง๐ ๐๐ฌ๐๐ซ
Hospitals & Clinics
Homecare Settings
Others)
๐๐ฒ ๐๐๐ ๐ข๐จ๐ง
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐
U.S.
Canada
Mexico
๐๐ฎ๐ซ๐จ๐ฉ๐
Germany
France
UK
Italy
Spain
Rest of Europe
๐๐ฌ๐ข๐-๐๐๐๐ข๐๐ข๐
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
๐๐๐๐๐
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ : https://www.alliedmarketresearch.com/purchase-enquiry/3740
๐
๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐?
Q1. What is the market value of Insulin Syringes Market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Insulin Syringes Market in 2020?
Q4. Which is base year calculated in the Insulin Syringes Market report?
Q5. Does the Insulin Syringes Market company is profiled in the report?
Q6. Which are the top companies hold the market share in Insulin Syringes Market?
Q7. Does the Insulin Syringes Market report provides Value Chain Analysis?
Q8. What are the key trends in the Insulin Syringes Market report?
๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:
๐๐ง๐ญ๐ข๐ง๐ฎ๐๐ฅ๐๐๐ซ ๐๐ง๐ญ๐ข๐๐จ๐๐ฒ ๐๐๐ฌ๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก, 2031 https://www.alliedmarketresearch.com/antinuclear-antibody-test-market
๐๐ข๐ง๐ ๐ฅ๐ ๐๐๐ฅ๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก, 2031 https://www.alliedmarketresearch.com/single-cell-analysis-market-A06188
๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ก๐ข๐ฌ๐ญ๐จ๐๐ก๐๐ฆ๐ข๐ฌ๐ญ๐ซ๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก, 2031 https://www.alliedmarketresearch.com/immunohistochemistry-market-A11199
๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐ก๐๐ซ๐ฆ๐๐๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก, 2031 https://www.alliedmarketresearch.com/compounding-pharmacies-market-A11920
๐๐๐ง๐๐จ๐ง ๐๐๐ฉ๐๐ข๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก, 2031 https://www.alliedmarketresearch.com/tendon-repair-market-A17088
๐๐ซ๐ญ๐ก๐จ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค – 2025 https://www.alliedmarketresearch.com/orthobiologics-market
David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
You just read:
EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswireโข, tries to define some of the boundaries that are reasonable in today’s world. Please see our Editorial Guidelines for more information.
Follow EIN Presswire
ยฉ 1995-2022 Newsmatics Inc. dba EIN Presswire
All Right Reserved.